441 related articles for article (PubMed ID: 10760364)
1. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
[TBL] [Abstract][Full Text] [Related]
2. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
3. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
Jakus R; Graf M; Juhasz G; Gerber K; Levay G; Halasz P; Bagdy G
Exp Neurol; 2003 Dec; 184(2):964-72. PubMed ID: 14769389
[TBL] [Abstract][Full Text] [Related]
4. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.
Overstreet DH; Knapp DJ; Moy SS; Breese GR
Psychopharmacology (Berl); 2003 Jun; 167(4):344-52. PubMed ID: 12677355
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
6. 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats.
Salchner P; Singewald N
Psychopharmacology (Berl); 2006 Apr; 185(3):282-8. PubMed ID: 16521035
[TBL] [Abstract][Full Text] [Related]
7. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
Dawson LA; Nguyen HQ
Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
9. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats.
Munzar P; Laufert MD; Kutkat SW; Nováková J; Goldberg SR
J Pharmacol Exp Ther; 1999 Oct; 291(1):239-50. PubMed ID: 10490910
[TBL] [Abstract][Full Text] [Related]
10. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.
Maura G; Marcoli M; Pepicelli O; Rosu C; Viola C; Raiteri M
Br J Pharmacol; 2000 Aug; 130(8):1853-8. PubMed ID: 10952674
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
12. The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats.
Cousins MS; Seiden LS
Psychopharmacology (Berl); 2000 Mar; 148(4):438-42. PubMed ID: 10928318
[TBL] [Abstract][Full Text] [Related]
13. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
[TBL] [Abstract][Full Text] [Related]
14. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
Durand M; Mormède P; Chaouloff F
Behav Pharmacol; 2003 Mar; 14(2):173-7. PubMed ID: 12658079
[TBL] [Abstract][Full Text] [Related]
15. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
Guptarak J; Sarkar J; Hiegel C; Uphouse L
Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
[TBL] [Abstract][Full Text] [Related]
17. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
